We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
(-8.4%)
Cap. Flow
-$592M
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtaiBeckley Inc
ATAI
|
+$25.3M |
| 2 |
Agilon Health
AGL
|
+$13.5M |
| 3 |
Eli Lilly
LLY
|
+$13.2M |
| 4 |
Privia Health
PRVA
|
+$12.8M |
| 5 |
Lantheus
LNTH
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$23.9M |
| 2 |
Vericel Corp
VCEL
|
+$20.8M |
| 3 |
Align Technology
ALGN
|
+$19M |
| 4 |
SI-BONE Inc
SIBN
|
+$17.5M |
| 5 |
STAAR Surgical
STAA
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.64% |
| 2 | Industrials | 1.41% |
| 3 | Materials | 0.54% |
| 4 | Financials | 0.48% |
| 5 | Consumer Staples | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $417M | 12.99% |
975,000
+125,000
| +15% | +$52.2M |
|
2
PUT
Invesco QQQ Trust
QQQ
$483B
| $292M | 9.1% |
825,000
-250,000
| -23% | -$84.1M |
|
3
PUT
iShares S&P 100 ETF
OEF
$20.5B
| $183M | 5.71% |
+800,000
| New | +$152M |
|
4
Establishment Labs
ESTA
$2.71B
| $91.5M | 2.85% |
1,047,275
-53,559
| -5% | -$3.98M |
|
5
PUT
ARK Innovation ETF
ARKK
$6.07B
| $78.5M | 2.44% |
600,000
-22,500
| -4% | -$2.62M |
|
|
IMDX
6
Insight Molecular Diagnostics
IMDX
$163M
| $70.2M | 2.18% |
611,198
| – | – |
|
|
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
| $69.8M | 2.17% |
10,575,351
+942,650
| +10% | +$5.03M |
|
|
NSTG
8
DELISTED
NanoString Technologies, Inc.
NSTG
| $68.5M | 2.13% |
1,057,215
+48,188
| +5% | +$3.06M |
|
9
PUT
Medtronic
MDT
$110B
| $62.1M | 1.93% |
500,000
+350,000
| +233% | +$43.9M |
|
10
PUT
ARK Genomic Revolution ETF
ARKG
$1.66B
| $55.5M | 1.73% |
600,000
-100,000
| -14% | -$8.5M |
|
|
INOV
11
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $54.7M | 1.7% |
1,604,973
-43,385
| -3% | -$1.34M |
|
12
CALL
Intellia Therapeutics
NTLA
$1.53B
| $49M | 1.52% |
302,400
+104,100
| +52% | +$8.11M |
|
13
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
| $47.4M | 1.47% |
+350,000
| New | +$52.4M |
|
14
AtriCure
ATRC
$1.98B
| $44.9M | 1.4% |
565,370
-50,580
| -8% | -$3.68M |
|
|
15
PUT
Intellia Therapeutics
NTLA
$1.53B
| $40M | 1.24% |
+246,900
| New | +$19.2M |
|
16
Inspire Medical Systems
INSP
$1.74B
| $39.4M | 1.23% |
203,996
-191
| -0.1% | -$37.9K |
|
17
PUT
HCA Healthcare
HCA
$88.5B
| $38.2M | 1.19% |
+185,000
| New | +$37.7M |
|
18
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $37.8M | 1.18% |
300,000
-700,000
| -70% | -$85.8M |
|
|
19
Intellia Therapeutics
NTLA
$1.53B
| $34.8M | 1.08% |
214,900
+24,900
| +13% | +$1.94M |
|
20
PUT
Illumina
ILMN
$29.9B
| $32.3M | 1.01% |
70,212
+5,962
| +9% | +$2.4M |
|
21
ICU Medical
ICUI
$4.17B
| $30.8M | 0.96% |
149,802
+1,254
| +0.8% | +$258K |
|
22
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $29.3M | 0.91% |
+250,000
| New | +$15M |
|
|
CUTR
23
DELISTED
Cutera, Inc.
CUTR
| $29.3M | 0.91% |
596,731
+95,926
| +19% | +$3.52M |
|
24
CALL
Intuitive Surgical
ISRG
$132B
| $27.6M | 0.86% |
+90,000
| New | +$25.2M |
|
|
25
STAAR Surgical
STAA
$1.15B
| $27M | 0.84% |
176,769
-110,469
| -38% | -$14.6M |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SR
PA
SCI
Pura Vida Investments's Q2 2021 Portfolio in Review
As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.
Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.
- Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
- Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
- Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
- Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
- Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
- Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
- Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.
Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.